Cookies on this site

This commentary aims to move the debate regarding the adoption of HbA 1c for diagnosis of type 2 diabetes forwards by highlighting the need to avoid addressing irrelevant questions, in particular, comparison of individuals diagnosed with different diagnostic criteria. Instead, we provide a list of important future questions, including whether adoption of HbA 1c as the primary diagnostic test improves uptake of diabetes screening, with resultant earlier diagnosis and improvement in outcomes. © Springer-Verlag 2012.

More information

DOI

10.1007/s00125-012-2510-8

Type

Journal article

Publication Date

01/06/2012

Volume

55

Pages

1564 - 1567

Total pages

3